Stocks Overview

LAST PRICE
82.7600
TODAY'S CHANGE (%)
Trending Up1.9200 (2.3751%)

Bid / Lots
82.7500/ 1
Ask / Lots
83.1400/ 1
Open / Previous Close
80.1600 / 80.8400
Day Range
Low 79.6300
High 82.9500
52 Week Range
Low 78.7500
High 120.5350
Volume
2,047,306
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 80.84
Time	Volume	HZNP
09:32 ET	16776	80.2
09:34 ET	8149	80.08
09:36 ET	11417	80.39
09:38 ET	8375	80.2403
09:39 ET	11236	80.365
09:41 ET	57259	80.865
09:43 ET	8117	81.06
09:45 ET	7149	81.005
09:48 ET	3900	81.29
09:50 ET	4551	81.28
09:52 ET	23906	80.975
09:54 ET	8293	81.14
09:56 ET	2015	81.125
09:57 ET	4100	81.08
09:59 ET	5100	81.36
10:01 ET	10952	81.44
10:03 ET	3000	81.52
10:06 ET	3500	81.84
10:08 ET	4311	81.925
10:10 ET	6900	82.1
10:12 ET	6461	82.345
10:14 ET	7074	82.22
10:15 ET	4800	82.24
10:17 ET	12800	82.38
10:19 ET	5771	82.57
10:21 ET	4069	82.785
10:24 ET	7650	82.685
10:26 ET	3216	82.56
10:28 ET	4200	82.79
10:30 ET	4814	82.65
10:32 ET	8100	82.735
10:33 ET	5437	82.57
10:35 ET	4620	82.735
10:37 ET	4141	82.795
10:39 ET	4000	82.86
10:42 ET	5554	82.815
10:44 ET	4300	82.73
10:46 ET	7000	82.63
10:48 ET	4505	82.49
10:50 ET	7589	82.64
10:51 ET	1787	82.64
10:53 ET	2600	82.58
10:55 ET	4111	82.6
10:57 ET	2249	82.58
11:00 ET	5752	82.6
11:02 ET	3100	82.57
11:04 ET	1600	82.55
11:06 ET	3300	82.37
11:08 ET	3123	82.52
11:09 ET	5127	82.51
11:11 ET	2979	82.51
11:13 ET	2400	82.46
11:15 ET	5502	82.575
11:18 ET	4302	82.67
11:20 ET	4603	82.64
11:22 ET	5346	82.53
11:24 ET	2134	82.44
11:26 ET	2115	82.46
11:27 ET	3354	82.47
11:29 ET	2835	82.44
11:31 ET	5401	82.35
11:33 ET	3125	82.39
11:36 ET	3300	82.31
11:38 ET	3340	82.33
11:40 ET	5043	82.335
11:42 ET	3948	82.3932
11:44 ET	5693	82.48
11:45 ET	6963	82.61
11:47 ET	3730	82.74
11:49 ET	16942	82.7004
11:51 ET	3318	82.59
11:54 ET	6410	82.46
11:56 ET	3100	82.46
11:58 ET	3893	82.39
12:00 ET	5877	82.3305
12:02 ET	2742	82.3
12:03 ET	4355	82.185
12:05 ET	3300	82.26
12:07 ET	2234	82.33
12:09 ET	1505	82.33
12:12 ET	5170	82.36
12:14 ET	2612	82.275
12:16 ET	4188	82.28
12:18 ET	3210	82.345
12:20 ET	2990	82.305
12:21 ET	3214	82.24
12:23 ET	2100	82.43
12:25 ET	3344	82.49
12:27 ET	1613	82.49
12:30 ET	5304	82.52
12:32 ET	2300	82.5215
12:34 ET	7525	82.58
12:36 ET	2800	82.62
12:38 ET	2400	82.59
12:39 ET	17289	82.58
12:41 ET	2812	82.495
12:43 ET	3944	82.5
12:45 ET	1500	82.495
12:48 ET	3741	82.5451
12:50 ET	2611	82.485
12:52 ET	3700	82.51
12:54 ET	4101	82.48
12:56 ET	915	82.51
12:57 ET	2987	82.39
12:59 ET	3984	82.51
01:01 ET	6464	82.52
01:03 ET	14194	82.48
01:06 ET	13028	82.44
01:08 ET	6511	82.43
01:10 ET	2643	82.465
01:12 ET	37312	82.5
01:14 ET	9107	82.48
01:15 ET	2524	82.445
01:17 ET	3900	82.5
01:19 ET	31675	82.6
01:21 ET	4390	82.54
01:24 ET	4600	82.5
01:26 ET	2999	82.33
01:28 ET	4458	82.27
01:30 ET	5116	82.22
01:32 ET	2000	82.22
01:33 ET	5731	82.16
01:35 ET	7189	82.14
01:37 ET	2374	82.25
01:39 ET	2169	82.23
01:42 ET	1800	82.25
01:44 ET	1993	82.25
01:46 ET	7003	82.05
01:48 ET	5321	82.04
01:50 ET	16167	82.05
01:51 ET	12574	82.16
01:53 ET	900	82.28
01:55 ET	3148	82.28
01:57 ET	2600	82.39
02:00 ET	4926	82.3
02:02 ET	10341	82.29
02:04 ET	13918	82.27
02:06 ET	5544	82.285
02:08 ET	12950	82.3
02:09 ET	4111	82.32
02:11 ET	2469	82.37
02:13 ET	4155	82.25
02:15 ET	2839	82.25
02:18 ET	3477	82.29
02:20 ET	1100	82.33
02:22 ET	1700	82.31
02:24 ET	2300	82.43
02:26 ET	3900	82.425
02:27 ET	4836	82.37
02:29 ET	2347	82.48
02:31 ET	2451	82.54
02:33 ET	3817	82.47
02:36 ET	2407	82.58
02:38 ET	2000	82.63
02:40 ET	3175	82.685
02:42 ET	2197	82.7
02:44 ET	4128	82.67
02:45 ET	9100	82.55
02:47 ET	3274	82.49
02:49 ET	4600	82.48
02:51 ET	3401	82.44
02:54 ET	2128	82.37
02:56 ET	3395	82.39
02:58 ET	3001	82.455
03:00 ET	7699	82.37
03:02 ET	5031	82.21
03:03 ET	2139	82.28
03:05 ET	31171	82.18
03:07 ET	19460	82.17
03:09 ET	8545	82.1403
03:12 ET	5375	82.13
03:14 ET	9258	82.2595
03:16 ET	25244	82.2
03:18 ET	8242	82.2
03:20 ET	12699	82.17
03:21 ET	7897	82.32
03:23 ET	5118	82.5
03:25 ET	4094	82.53
03:27 ET	3873	82.5
03:30 ET	7638	82.55
03:32 ET	8014	82.545
03:34 ET	4399	82.71
03:36 ET	5277	82.73
03:38 ET	7154	82.66
03:39 ET	5913	82.7
03:41 ET	6148	82.69
03:43 ET	5357	82.74
03:45 ET	9315	82.75
03:48 ET	14505	82.79
03:50 ET	9822	82.885
03:52 ET	13888	82.875
03:54 ET	18857	82.84
03:56 ET	35461	82.745
03:57 ET	35620	82.76
03:59 ET	62777	82.76

Data delayed at least 15 minutes.

Today
- UBS Lowers Horizon Therapeutics' Price Target to $137 From $139, Maintains Buy Rating, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
Jun 24, 2022
- New Analysis Finds UPLIZNA(R) (inebilizumab) Effective Among European Populations with Neuromyelitis Optica Spectrum Disorder (NMOSD), from 12:30PM ET on Friday Jun 24, 2022 by Business Wire
  12:30PM ET on Friday Jun 24, 2022 by Business Wire
Jun 15, 2022
- Horizon Therapeutics Files for Brazilian Approval of Autoimmune Disease Treatment, from 9:37AM ET on Wednesday Jun 15, 2022 by MT Newswires
  9:37AM ET on Wednesday Jun 15, 2022 by MT Newswires
- Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA(R) (inebilizumab) in Brazil, from 8:30AM ET on Wednesday Jun 15, 2022 by Business Wire
  8:30AM ET on Wednesday Jun 15, 2022 by Business Wire
- Horizon Therapeutics plc Named One of the Fortune Best Workplaces in Chicago(TM), from 7:45AM ET on Wednesday Jun 15, 2022 by Business Wire
  7:45AM ET on Wednesday Jun 15, 2022 by Business Wire

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesHZNP Horizon Therapeutics PLC	18.6B	22.7x	---
United StatesINCY Incyte Corp	17.2B	18.9x	+51.40%
United StatesCTLT Catalent Inc	19.2B	38.2x	+28.57%
United StatesJAZZ Jazz Pharmaceuticals PLC	9.9B	-21.3x	---
United StatesNVO Novo Nordisk A/S	194.3B	37.0x	+6.74%
United StatesRPRX Royalty Pharma PLC	26.0B	43.3x	---
As of 2022-07-05

Horizon Therapeutics plc is a biotechnology company that is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare, autoimmune and serious inflammatory diseases. The Company's portfolio is composed of approximately 12 medicines in the areas of rare diseases, gout, ophthalmology and inflammation. The Company has two reportable segments: the orphan and the inflammation segment. The orphan segment includes the medicines TEPEZZA, KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, UPLIZNA and also the Company’s research and development (R&D) programs. TEPEZZA is a monoclonal antibody and a targeted inhibitor of the insulin-like growth factor-1 receptor (IGF-1R). KRYSTEXXA is an infused medicine for uncontrolled gout. The Company's other orphan segment medicines, RAVICTI, PROCYSBI and ACTIMMUNE, treats serious chronic diseases. The inflammation segment includes PENNSAID 2%, DUEXIS, RAYOS and VIMOVO medicines.

Contact Information

Headquarters: Connaught House 1St Floor, 1 Burlington RoadDUBLIN, Ireland D04 C5Y6
Phone: ---
Fax: ---

Executives

Chairman of the Board, President, Chief Executive Officer: Timothy Walbert
Chief Financial Officer, Executive Vice President: Aaron Cox
Executive Vice President, General Counsel: Sean Clayton
Executive Vice President - Technical Operations and Corporate Quality: Michael DesJardin
Executive Vice President, President - International: Vikram Karnani

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

Fundamentals Table
Market Cap	$18.6B
Revenue (TTM)	$3.8B
Shares Outstanding	229.9M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.16
EPS	$3.65
Book Value	$20.55
P/E Ratio	22.7x
Price/Sales (TTM)	4.9
Price/Cash Flow (TTM)	15.0x
Operating Margin	23.81%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Horizon Therapeutics PLC
NASDAQ:HZNPUnited States

Search Criteria

Charts

Recent News

Today

UBS Lowers Horizon Therapeutics' Price Target to $137 From $139, Maintains Buy Rating, from 7 hours ago by MT Newswires

Jun 24, 2022

New Analysis Finds UPLIZNA(R) (inebilizumab) Effective Among European Populations with Neuromyelitis Optica Spectrum Disorder (NMOSD), from 12:30PM ET on Friday Jun 24, 2022 by Business Wire

Jun 15, 2022

Horizon Therapeutics Files for Brazilian Approval of Autoimmune Disease Treatment, from 9:37AM ET on Wednesday Jun 15, 2022 by MT Newswires

Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA(R) (inebilizumab) in Brazil, from 8:30AM ET on Wednesday Jun 15, 2022 by Business Wire

Horizon Therapeutics plc Named One of the Fortune Best Workplaces in Chicago(TM), from 7:45AM ET on Wednesday Jun 15, 2022 by Business Wire

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar